Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 11:45AM CDT
AEC: 28.49 (+4.01), SMCI: 31.90 (-2.91), CAMP: 20.87 (+4.19), GEVO: 2.78 (+0.77), DSKX: 1.64 (+0.30), CCIH: 14.86 (+2.54), ENZN: 1.70 (+0.20), NRP: 5.54 (-1.38), PARN: 4.19 (-0.30), GBSN: 4.98 (+1.44), AMSC: 10.40 (+1.20), PW: 6.33 (-2.95), EARS: 4.65 (-0.75), EMMS: 1.61 (-0.24), COOL: 1.40 (-0.21), LOOK: 1.75 (-0.51), ONVO: 5.14 (+0.67), HMNY: 2.90 (-0.63), PKT: 11.42 (+1.91), ZHNE: 1.89 (+0.36)
Premarket Gainers / Losers as of 9:15 am
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 8:15AM CDT
BRCM: 46.18 (+2.20), CSLT: 7.85 (+0.36), NVGN: 7.40 (-0.30), ASML: 107.81 (+10.06), VICL: 1.01 (-0.02), NRP: 5.54 (-1.38), ENZN: 1.70 (+0.20), GBSN: 4.98 (+1.44), LOOK: 1.75 (-0.51), ONVO: 5.14 (+0.67), CMG: 641.23 (-51.29), ANGI: 6.46 (+0.31), PKT: 11.42 (+1.91)
Organovo inks collaboration deal with Merck; shares up 17% premarket
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 7:50AM CDT
ONVO: 5.14 (+0.67), MRK: 57.69 (+0.03)
Organovo Holdings, Inc. Pre-Announces Preliminary Fiscal 2015 Fourth Quarter And Year End Financial Information
PR Newswire - Tue Apr 21, 4:05PM CDT
Organovo Holdings, Inc. (NYSE MKT: ONVO) today announced preliminary financial information (unaudited) for the fourth quarter and fiscal year ended March 31, 2015.
ONVO: 5.14 (+0.67)
Can Organovo Holdings Inc. Bounce Back?
Rick Munarriz, The Motley Fool - Motley Fool - Fri Apr 17, 7:03AM CDT
Source: Organovo. One of last week's biggest winners was Organovo Holdings , climbing nearly 12% after Cantor Fitzgerald initiated coverage of the volatile bioprinting specialist with a bullish "buy" rating. The analyst is slapping a $5 price...
ONVO: 5.14 (+0.67)
Should L'Oreal Worry About Estee Lauder?
Stock Ticker - at Seeking Alpha - Fri Apr 17, 1:02AM CDT
ONVO: 5.14 (+0.67), EL: 82.42 (-0.31)
3D printing stocks up strongly amid NYC conference
Seeking Alpha - at Seeking Alpha - Wed Apr 15, 11:32AM CDT
ARCW: 7.06 (-0.57), MTLS: 6.88 (+0.23), VJET: 8.77 (-0.06), ONVO: 5.14 (+0.67), DDD: 30.55 (-0.61), SSYS: 53.60 (+0.17)
Critical Alerts For GoDaddy, Disney, Arrowhead Research, Merrimack Pharmaceuticals and Organovo Released By InvestorsObserver
PR Newswire - Tue Apr 14, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for GDDY, DIS, ARWR, MACK and ONVO.
MACK: 13.44 (+0.18), ARWR: 6.87 (+0.13), ONVO: 5.14 (+0.67), DIS: 107.94 (+0.26), GDDY: 24.77 (-0.01)
Bull vs. Bear: Organovo Stock
Brian Stoffel, The Motley Fool - Motley Fool - Mon Apr 13, 6:09AM CDT
Take a company with seemingly limitless potential, but almost no revenue coming in to speak of, and you have the perfect recipe for volatility. That's the case with Organovo , a 3-D bioprinting company making fully functioning human tissues for...
ONVO: 5.14 (+0.67)
Organovo Holdings Inc. Shares Cratered in March -- Here's Why
Sean Williams, The Motley Fool - Motley Fool - Thu Apr 09, 11:02AM CDT
What: Shares of Organovo Holdings , a 3D tissue engineering company focused on developing products that can assist in the drug discovery process and could someday be implanted, fell 40% in March according to data from S&P Capital IQ after...
ONVO: 5.14 (+0.67)
Weak On High Volume: Organovo Holdings (ONVO)
at The Street - Thu Apr 09, 9:03AM CDT
Trade-Ideas LLC identified Organovo Holdings (ONVO) as a weak on high relative volume candidate
ONVO: 5.14 (+0.67)
Three Small Cap Stocks That Are Being Overlooked By Wall Street
ACCESSWIRE - Wed Apr 08, 6:25PM CDT
NEW YORK, NY / ACCESSWIRE / April 8, 2015 / With extremely volatile equity markets numerous small cap companies have presented incredible upside opportunities for investors. However, countless companies remain unnoticed and forgotten by analysts, journalists, and investors. There are several companies that we have uncovered that merit more attention in our opinion due to underlying fundamental, industry and technical factors. Organovo Holdings, Inc. (NYSE: ONVO), BIND Therapeutics, Inc. (NASDAQ: BIND) and ForceField Energy Inc. (NASDAQ: FNRG), despite their differing industries, present traders and investors with similar factors that are capable of providing incredible upside opportunity.
FNRG: 3.11 (-0.86), ONVO: 5.14 (+0.67), PFE: 34.93 (+0.04), BIND: 7.01 (-0.30)
Organovo Holdings (ONVO) Stock Surges Today on Cantor Fitzgerald Coverage Initiation
at The Street - Wed Apr 08, 10:35AM CDT
Shares of Organovo Holdings (ONVO) rose in late morning trading Wednesday after Cantor Fitzgerald initiated coverage on the stock with a 'buy' rating and a $5 price target.
ONVO: 5.14 (+0.67)
Critical Alerts For Organovo, 500.Com, Chevron, Delphi Automotive and UnitedHealth Released By InvestorsObserver
PR Newswire - Wed Apr 08, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ONVO, WBAI, CVX, DLPH and UNH.
ONVO: 5.14 (+0.67), UNH: 117.81 (-1.47), CVX: 109.50 (-0.23), DLPH: 82.88 (-0.15), WBAI: 16.75 (-0.46)
Organovo up modestly after hours on Cantor's Buy rating
Seeking Alpha - at Seeking Alpha - Tue Apr 07, 3:44PM CDT
ONVO: 5.14 (+0.67)
Organovo inks collaboration deal with L'Oreal USA
Seeking Alpha - at Seeking Alpha - Tue Apr 07, 7:56AM CDT
ONVO: 5.14 (+0.67)
Seeking Alpha's Biotech Weekly: Billion Dollar Deals, Gilead Earnings Preview, And More
SA Editor Mike Taylor - at Seeking Alpha - Fri Apr 03, 3:00PM CDT
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
VRX: 206.93 (-3.92), MDT: 78.01 (+0.93), VVUS: 2.50 (+0.04), ASPX: 100.79 (+0.09), MNKD: 4.90 (-0.09), NUVA: 43.38 (+0.10), HPTX: 45.96 (-0.18), ZTS: 47.03 (-0.51), GILD: 104.18 (-1.02), ONVO: 5.14 (+0.67), HZNP: 30.96 (+0.10), TEVA: 63.01 (-1.15), EXEL: 3.12 (+0.05)
Apparent Connections To A Convicted Stock Promoter: Another Chapter In The Organovo Saga
Alpha Exposure - Seeking Alpha - Wed Apr 01, 12:16PM CDT
Much has been written about Organovo (NYSEMKT: ONVO ) and its shortcomings. Richard Pearson showed that Organovo's 3D liver tissue is not unique, that competitors are more advanced than ONVO, and that the market opportunity for liver assays is...
ONVO: 5.14 (+0.67)